Skip to main content
BIVI
NASDAQ Life Sciences

BioVie Files $300M Universal Shelf Registration Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.75
Mkt Cap
$13.274M
52W Low
$1.06
52W High
$11.1
52W Position info
65% above low
Off High info
84% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

BIVI sits 65% above its 52-week low of $1.06.

Summary

BioVie Inc. filed an S-3 shelf registration to potentially raise up to $300 million, a crucial step for the cash-strapped company facing a "going concern" warning, though immediate sales are limited by SEC rules.


Key Events · Financing and Capital Events · BIVI

  • Universal Shelf Registration

    BioVie registered to sell up to $300 million in common stock, preferred stock, warrants, debt, rights, or units from time to time.

  • Addresses Going Concern

    This filing provides a mechanism for the company to raise capital, which is critical given its recent "going concern" warning and cash shortage.

  • Significant Potential Dilution

    The registered amount is substantial relative to the company's current market capitalization, indicating significant potential future dilution.

  • Immediate Offering Limit

    Due to SEC rules (Form S-3, General Instruction I.B.6), the company is currently limited to selling approximately $4.2 million in primary offerings over any 12-month period.


Analysis · BIVI · Life Sciences

BioVie Inc. has filed a universal shelf registration statement to allow for the potential sale of up to $300 million in various securities. This move is critical for the company, which recently reported a "going concern" warning and a severe cash shortage. While the registration provides a mechanism for future capital raises, current SEC rules (Form S-3, General Instruction I.B.6) limit primary offerings to approximately $4.2 million over any 12-month period due to the company's small non-affiliate market value. This registration signals the company's intent to address its financial needs, but also introduces significant potential dilution for existing shareholders.

At the time of this filing, BIVI was trading at $1.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.3M. The 52-week trading range was $1.06 to $11.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIVI - Latest Insights

BIVI
Jul 31, 2026, 5:29 PM EDT
Filing Type: S-1/A
Importance Score:
8
Price at Filing: $1.48
Real-time Price: $1.52 info
Change: +$0.0376 (+3%) info
Market Cap: $11.464M info
BIVI
Jul 17, 2026, 5:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.52 info
Change: +$0.0476 (+3%) info
Market Cap: $11.464M info
BIVI
Jul 17, 2026, 5:21 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $1.80
Real-time Price: $1.52 info
Change: -$0.2824 (-16%) info
Market Cap: $11.464M info
BIVI
Jun 05, 2026, 3:31 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.52 info
Change: -$0.0624 (-4%) info
Market Cap: $11.464M info
BIVI
May 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.52 info
Change: +$0.1876 (+14%) info
Market Cap: $11.464M info